Autologous T cells with NY-ESO-1-specific T-cell receptor (GSK3377794) in HLA-A*02+ previously-treated and -untreated advanced metastatic/unresectable synovial sarcoma: A master protocol study design Meeting Abstract


Authors: D'Angelo, S.; Blay, J. Y.; Chow, W.; Demetri, G.; Thistlethwaite, F.; Wagner, M.; Loeb, D.; Attia, S.; Razak, A.; Haanen, J.; Hasan, A.; Billiard, J.; Pearce, L.; Wu, Y.; Ji, R.; Johnson, L.; Srinath, C.; Shalabi, A.; Strauss, S.; Thornton, K.; Mackall, C.; Tap, W.; Van Tine, B.
Abstract Title: Autologous T cells with NY-ESO-1-specific T-cell receptor (GSK3377794) in HLA-A*02+ previously-treated and -untreated advanced metastatic/unresectable synovial sarcoma: A master protocol study design
Meeting Title: 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 7
Issue: Suppl. 1
Meeting Dates: 2019 Nov 6-10
Meeting Location: National Harbor, MD
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2019-11-01
Start Page: 282
Language: English
ACCESSION: WOS:000496473200873
PROVIDER: wos
PMCID: PMC6833189
PUBMED: 31694725
DOI: 10.1186/s40425-019-0763-1
Notes: Meeting Abstract: P453 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sandra Pierina D'Angelo
    252 D'Angelo
  2. William Douglas Tap
    372 Tap